Disease Characteristics And Outcome Of Patients (Pts) With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Who Received A Beta Emitter (177lu-Psma) After An Alpha Emitter (Radium-223).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 2|浏览38
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要